Therapeutic Areas

Latest News

Image credit: klickit24 | stock.adobe.com
Potential First in Class Treatment for Cirrhosis Shows Positive Results in Phase II Trial

March 28th 2024

LPCN 1148 is an oral treatment that has shown promise preventing recurrence of overt hepatic encephalopathy and treating sarcopenia.

Image credit: pressmaster | stock.adobe.com
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia

March 27th 2024

Designing Clinical Studies in Pain Management
Designing Clinical Studies in Pain Management

March 27th 2024

Image credit: neirfy | stock.adobe.com
Phase III NextCOVE Trial Data Show Efficacy of Moderna's Next-Generation COVID-19 Vaccine

March 26th 2024

The State of the Opioid Epidemic
The State of the Opioid Epidemic

March 26th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.